Aoxing Pharmaceutical Company Inc
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiq… Read more
Aoxing Pharmaceutical Company Inc (AOXG) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2017: -0.167x
Based on the latest financial reports, Aoxing Pharmaceutical Company Inc (AOXG) has a cash flow conversion efficiency ratio of -0.167x as of March 2017.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.02 Million) by net assets ($18.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aoxing Pharmaceutical Company Inc - Cash Flow Conversion Efficiency Trend (2005–2016)
This chart illustrates how Aoxing Pharmaceutical Company Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aoxing Pharmaceutical Company Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aoxing Pharmaceutical Company Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Global Bioenergies SA
F:1DK
|
N/A |
|
ADMIRAL GROUP - Dusseldorf Stock Exchang
DU:FLN
|
N/A |
|
Wingara AG Ltd
AU:WNR
|
-1.348x |
|
Jubilant Flame International Ltd
OTCQB:JFIL
|
0.011x |
|
Ready Set Gold Corp
PINK:RDYFF
|
0.002x |
|
Hydrocarbon Dynamics Limited
PINK:PYMOF
|
-0.355x |
|
BANKUNITED
BE:BNU
|
0.016x |
|
Birman Wood and Hardware Ltd
TA:BIRM
|
0.042x |
Annual Cash Flow Conversion Efficiency for Aoxing Pharmaceutical Company Inc (2005–2016)
The table below shows the annual cash flow conversion efficiency of Aoxing Pharmaceutical Company Inc from 2005 to 2016.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2016-06-30 | $18.08 Million | $-534.99K | -0.030x | -109.84% |
| 2015-06-30 | $10.06 Million | $3.03 Million | 0.301x | -84.41% |
| 2014-06-30 | $-4.01 Million | $-7.73 Million | 1.928x | +206.27% |
| 2013-06-30 | $4.58 Million | $-8.32 Million | -1.815x | -2809.61% |
| 2012-06-30 | $21.27 Million | $-1.33 Million | -0.062x | +10.59% |
| 2011-06-30 | $38.32 Million | $-2.67 Million | -0.070x | +39.86% |
| 2010-06-30 | $34.31 Million | $-3.98 Million | -0.116x | -344.68% |
| 2009-06-30 | $24.64 Million | $-642.60K | -0.026x | +33.24% |
| 2008-06-30 | $25.16 Million | $-982.95K | -0.039x | +55.03% |
| 2007-06-30 | $12.23 Million | $-1.06 Million | -0.087x | +46.57% |
| 2006-06-30 | $4.52 Million | $-734.57K | -0.163x | -775.01% |
| 2005-06-30 | $5.09 Million | $-94.52K | -0.019x | -- |